|
|
3M-052-Alum |
|
Vaxjo ID |
141 |
|
Vaccine Adjuvant Name |
3M-052-Alum |
|
Adjuvant VO ID |
VO_0005387
|
|
Description |
mineral salt, compound adjuvant of synthetic derivative of natural compound with TLR7 and TLR8 receptors, induce th1 response |
|
Stage of Development |
Clinical Trial |
|
Location Licensed |
United States |
|
Host Species for Testing |
2 |
|
Second Host Species for Testing |
3 |
|
Components |
3M-052 |
|
Storage |
2-8C |
|
Preparation |
For clinical uses, 3M-052-Alum is formulated by using 3M-052-AF with an antigen adsorbed to Alum. |
|
Function |
innate immune activation |
| References |
|
|
